Metabolic bone disease: a continued challenge in extremely low birth weight infants

Sreekanth Viswanathan1, Wasim Khasawneh2, Kera McNelis3

  • 1Division of Neonatology, Department of Pediatrics, Rainbow Babies & Children's Hospital, University Hospitals, Cleveland, OH, USA.

Insights

Metabolic bone disease (MBD) affects nearly one-third of extremely low birth weight (ELBW) infants, often linked to lower nutrient intake and increased medical interventions. This condition is associated with higher mortality and longer hospital stays in these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Metabolic bone disease (MBD) is a significant complication in premature infants, particularly those with extremely low birth weight (ELBW).
  • Research on MBD in ELBW infants is limited despite their high risk.
  • Understanding MBD incidence and risk factors in ELBW infants is crucial for improving outcomes.

Purpose of the Study:

  • To determine the incidence of MBD in extremely low birth weight (ELBW) infants.
  • To identify risk factors associated with MBD development in this population.
  • To describe the clinical characteristics and outcomes of ELBW infants with MBD.

Main Methods:

  • Retrospective analysis of ELBW infants admitted between 2005 and 2010, surviving over 8 weeks.
  • MBD diagnosis based on radiographic evidence of osteopenia or rickets.
  • Comparison of clinical characteristics, nutrient intake, and outcomes between infants with and without MBD.

Main Results:

  • The incidence of radiological MBD was 30.9% (71/230) in ELBW infants.
  • Infants with MBD were smaller, more premature, and had higher rates of mechanical ventilation, chronic lung disease, and prolonged parenteral nutrition.
  • Lower intake of calcium, phosphorus, vitamin D, protein, and calories was observed in MBD cases, associated with increased mortality and hospital stay.

Conclusions:

  • MBD remains a prevalent issue in ELBW infants, even with advancements in neonatal nutrition.
  • Factors such as prematurity, low birth weight, and specific medical interventions are linked to MBD.
  • Optimizing chronic lung disease management and early nutritional strategies is essential for reducing MBD in ELBW infants.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
The Functions of the Skeletal System01:22

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...